Evotec SE (EVO) Cash from Operations (2009 - 2026)
Evotec SE (EVO) posted Cash from Operations of 4584.64 for Q1 2026, up 99.96% sequentially from 10600002.58 in Q4 2025, and up 86.3% YoY from 2460.92 in Q1 2025.
Evotec SE (EVO) Cash from Operations (2009 - 2026) Analysis & Trends
Evotec SE has reported Cash from Operations for 9 years, with the latest figure at 4584.64 in Q1 2026.
- Quarterly Cash from Operations rose 86.3% year-over-year to 4584.64 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 10653504.75 (down 154.67% YoY) and the FY2025 annual result came in at 10684755.42, down 154.88% from the prior year.
- Cash from Operations advanced to 4584.64 in Q1 2026 per EVO's latest filing, from 10600002.58 in the prior quarter.
- Over five years, Cash from Operations peaked at 209736706.3 in Q4 2022 and troughed at 10600002.58 in Q4 2025.
- A 5-year average of 15175421.3 and a median of 671.91 in 2023 frame the typical range for Cash from Operations.
- The sharpest annual moves came in 2022 and 2024: Cash from Operations surged 2407103.0% in 2022, then slumped 7889.36% in 2024.
- Over 5 years, Cash from Operations stood at 209736706.3 in 2022, then tumbled by 81.32% to 39188426.71 in 2023, then tumbled by 50.16% to 19529648.46 in 2024, then sank by 154.28% to 10600002.58 in 2025, then surged by 99.96% to 4584.64 in 2026.
- According to Business Quant data, Cash from Operations over the past three periods registered 4584.64, 10600002.58, and 78977.85 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.54 Bn | 43.57 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.59 Bn | 39.94 Bn | 2.15 Bn | 411.00 Mn |
| 3 | Zoetis | 32.41 Bn | 30.73 Bn | 1.05 Bn | 655.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.84 Bn | 5.10 Bn | 800.69 Mn |
| 5 | United Therapeutics | 22.00 Bn | 19.34 Bn | 683.80 Mn | 313.60 Mn |
| 6 | Viatris | 19.03 Bn | 18.14 Bn | 1.46 Bn | 381.80 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 136.40 Mn |
| 8 | Elanco Animal Health | 12.01 Bn | 11.48 Bn | 798.00 Mn | 277.00 Mn |
| 9 | Dr Reddys Laboratories | 10.15 Bn | 9.99 Bn | - | - |
| 10 | Evotec SE | 687.23 Mn | 686.75 Mn | - | -4,584.64 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4,584.64 |
| Mar 31, 2026 | -4,584.64 |
| Dec 31, 2025 | -10.60 Mn |
| Dec 31, 2025 | -10.60 Mn |
| Sep 30, 2025 | -78,977.85 |
| Sep 30, 2025 | -78,977.85 |
| Jun 30, 2025 | 30,060.32 |
| Jun 30, 2025 | 30,060.32 |
| Mar 31, 2025 | -33,458.34 |
| Mar 31, 2025 | -33,458.34 |
| Dec 31, 2024 | 19.53 Mn |
| Dec 31, 2024 | 19.53 Mn |
| Sep 30, 2024 | 46,783.05 |
| Sep 30, 2024 | 46,783.05 |
| Jun 30, 2024 | -54,297.75 |
| Jun 30, 2024 | -54,297.75 |
| Mar 31, 2024 | -52,337.65 |
| Mar 31, 2024 | -52,337.65 |
| Dec 31, 2023 | 39.19 Mn |
| Dec 31, 2023 | 39.19 Mn |